Leap Therapeutics Inc. (LPTX) NASDAQ
$2.66 (0.12) (-4.32%)
Market Cap: $71.17M
As of 03/28/24 04:00 PM EDT. Market closed.
Leap Therapeutics Inc. (LPTX)
NASDAQ
$2.66
(0.12) (-4.32%)
Market Cap: $71.17M
As of 03/28/24 04:00 PM EDT. Market closed.
leap therapeutics (nasdaq: lptx) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. for more information about leap therapeutics, visit http://www.leaptx.com or our public filings with the sec that are available via edgar at http://www.sec.gov or via ... read more
leap therapeutics (nasdaq: lptx) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. for more information about leap therapeutics, visit http://www.leaptx.com or our public filings with the sec that are available via edgar at http://www.sec.gov or via http://www.investors.leaptx.com. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
BeiGene, Ltd. | 10% Owner | Sep 24, 2021 | Buy | $2.85 | 2,543,800 | 7,249,830 | 7,348,437 | Sep 28, 2021, 05:48 PM |
PERCEPTIVE ADVISORS LLC | 10% Owner | Jun 22, 2020 | Buy | $2.00 | 1,750,000 | 3,500,000 | 8,476,496 | Jun 24, 2020, 07:00 PM |
ONSI DOUGLAS E | CFO, GC, Treasurer & Secretary | Feb 05, 2019 | Buy | $1.75 | 571,428 | 999,999 | 4,114,804 | Feb 05, 2019, 04:22 PM |
LAWLOR AUGUSTINE | Chief Operating Officer | Feb 05, 2019 | Buy | $1.75 | 571,428 | 999,999 | 4,114,804 | Feb 05, 2019, 04:21 PM |
Mirabelli Christopher | CEO, President, Chairman | Feb 05, 2019 | Buy | $1.75 | 571,428 | 999,999 | 4,114,804 | Feb 05, 2019, 04:20 PM |
HealthCare Ventures IX, L.P. | 10% Owner | Feb 05, 2019 | Buy | $1.75 | 571,428 | 999,999 | 4,144,804 | Feb 05, 2019, 04:19 PM |
ONSI DOUGLAS E | CFO, GC, Treasurer & Secretary | Nov 14, 2017 | Buy | $6.09 | 1,057,769 | 6,436,524 | 3,573,376 | Nov 16, 2017, 01:45 PM |
Mirabelli Christopher | CEO, President, COB | Nov 14, 2017 | Buy | $6.09 | 1,057,769 | 6,436,524 | 3,573,376 | Nov 16, 2017, 01:45 PM |
HealthCare Ventures IX, L.P. | 10% Owner | Nov 14, 2017 | Buy | $6.09 | 1,057,769 | 6,436,524 | 3,573,376 | Nov 16, 2017, 01:45 PM |
LAWLOR AUGUSTINE | Chief Operating Officer | Nov 14, 2017 | Buy | $6.09 | 1,057,769 | 6,436,524 | 3,573,376 | Nov 16, 2017, 01:45 PM |
Owner | Relationship | Date | Value($) |
BeiGene, Ltd. | 10% Owner | 09/24/2021 | 7,249,830 |
PERCEPTIVE ADVISORS LLC | 10% Owner | 06/22/2020 | 3,500,000 |
ONSI DOUGLAS E | CFO, GC, Treasurer & Secretary | 02/05/2019 | 999,999 |
LAWLOR AUGUSTINE | Chief Operating Officer | 02/05/2019 | 999,999 |
Mirabelli Christopher | CEO, President, Chairman | 02/05/2019 | 999,999 |
HealthCare Ventures IX, L.P. | 10% Owner | 02/05/2019 | 999,999 |
ONSI DOUGLAS E | CFO, GC, Treasurer & Secretary | 11/14/2017 | 6,436,524 |
Mirabelli Christopher | CEO, President, COB | 11/14/2017 | 6,436,524 |
HealthCare Ventures IX, L.P. | 10% Owner | 11/14/2017 | 6,436,524 |
LAWLOR AUGUSTINE | Chief Operating Officer | 11/14/2017 | 6,436,524 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BAKER BROS. ADVISORS LP | 1,172,175 | 0.06% | No change | Other |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 942,918 | 0.00809% | No change | Other |
UBS OCONNOR LLC | 143,589 | 0.04% | -34.56% | Value |
GEODE CAPITAL MANAGEMENT, LLC | 203,960 | 0.00009% | 41.96% | Other |
BLACKROCK INC. | 95,156 | 0.00001% | 112.48% | Other |
RENAISSANCE TECHNOLOGIES LLC | 14,450 | 0.00009% | New | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View